Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.
- CAS Registry Number
- 75567-37-2
- Molecular formula
- C25H34O6
- Molecular weight
- 430.5 g/mol
- Drug class
- Diterpene estertopical cytotoxic agent for actinic keratosis (withdrawn in EU)
- Mechanism of action
- Induces rapid cell death and inflammatory responses in treated epidermal cells. The precise molecular pathways are not fully defined; post-marketing evidence raised concerns about increased risk of skin malignancies.
- Indications / reported uses
- Historical topical indication: treatment of actinic keratosis in adults. The EU marketing authorisation for Picato was withdrawn in 2020 following concerns about skin malignancy risk; it should not be presented as a currently authorised EU treatment.
Identification source: PubChem record (CID 6918670). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.